The Rhenium-SCT® (Skin Cancer Therapy) is a brachytherapy utilizing the Beta emitter radioisotope Rhenium-188 for the treatment of Non-Melanoma Skin Cancer.

The main objective of the Rhenium-SCT® is to be a painless, personalized, non-invasive therapy targeting and destroying cancer cells in the area needed to treat.

Medical working principle

This epidermal radioisotope therapy is based on the local direct cell-killing effect of the beta-radiation, which triggers both the local death of cells and local reactions of the immune system of the body to repair itself.

Get in touch with our Sales Team

If you are in need of any further information regarding sources, please contact us at sales@vonbv.com.

We will guarantee you the best service possible on providing information and helping you out with the best choice for your department. We are very experienced with the logistics due to our worldwide network.


Rhenium-SCT Basic info for Physicians and Healthcare Professionals catalogue


Rhenium-SCT FAQ Physicians and Medical personnel catalogue